Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved Optune Pax (R) for the treatment of adult patients with locally advanced pancreatic cancer concomitant ...

Novocure (Nasdaq:NVCR) announced that the FDA granted approval for its Optune Pax treatment for advanced pancreatic cancer.

According to the latest tokenized commodities market data, Tether Gold and PAX Gold have driven the value of total assets ...

Optune Pax concomitant with gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancerPhase 3 PANOVA-3 trial showed a ...

At a time when almost every major cryptocurrency is in the red, these two cryptos are soaring higher.

NovoCure Ltd NVCR shares are trending on Thursday. Shares of the oncology company surged 29.52% to $13.60 in after-hours trading on Wednesday after the Food and Drug Administration approved Optune Pax ...

The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally ...

With Season 2 fast approaching, EA reveals new details on what Battlefield 6 players can expect to see in regards to ...

The use of the word "pause" indicates that development on the Switch 2 port of Borderlands 4 could, theoretically, resume in the future, as it's not technically cancelled, but there's no guarantee ...

The dollar, battered by disruption to the rules-based global order, stands at center stage in an unfolding drama of market ...

Castle Biosciences, Inc. (CSTL) has been beaten down lately with too much selling pressure. While the stock has lost 16.8% over the past four weeks, there is light at the end of the tunnel as it is ...

After answering many community questions about their plans for Pax Dei's new Master Crafting feature, Mainframe Industries announced that the first part of the next update will hit the Arcadia public ...